Medical Care
Global Angiotensin II Receptor Blocker (ARBs) API Market Research Report 2025
- Jul 08, 25
- ID: 348428
- Pages: 90
- Figures: 81
- Views: 8
The global market for Angiotensin II Receptor Blocker (ARBs) API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Valsartan, losartan, irbesartan and other “-sartan” drugs are a class of medicines known as angiotensin II receptor blocker (ARBs) used to treat high blood pressure and heart failure.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Angiotensin II Receptor Blocker (ARBs) API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensin II Receptor Blocker (ARBs) API.
The Angiotensin II Receptor Blocker (ARBs) API market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Angiotensin II Receptor Blocker (ARBs) API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiotensin II Receptor Blocker (ARBs) API companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceutical
Aurobindo Pharma
Viatris
Tianyu Pharma
Huahai Pharmaceutical
Menovo
Rundu Pharma
Kinglyuan Pharmaceutical
Second Pharma
Apeloa
Jiangxi Synergy Pharmaceutical
Segment by Type
Valsartan
Irbesartan
Telmisartan
Losartan
Candesartan
Olmesartan
Others
Segment by Application
Essential Hypertension
Secondary Hypertension
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Angiotensin II Receptor Blocker (ARBs) API company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Valsartan, losartan, irbesartan and other “-sartan” drugs are a class of medicines known as angiotensin II receptor blocker (ARBs) used to treat high blood pressure and heart failure.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Angiotensin II Receptor Blocker (ARBs) API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensin II Receptor Blocker (ARBs) API.
The Angiotensin II Receptor Blocker (ARBs) API market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Angiotensin II Receptor Blocker (ARBs) API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiotensin II Receptor Blocker (ARBs) API companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceutical
Aurobindo Pharma
Viatris
Tianyu Pharma
Huahai Pharmaceutical
Menovo
Rundu Pharma
Kinglyuan Pharmaceutical
Second Pharma
Apeloa
Jiangxi Synergy Pharmaceutical
Segment by Type
Valsartan
Irbesartan
Telmisartan
Losartan
Candesartan
Olmesartan
Others
Segment by Application
Essential Hypertension
Secondary Hypertension
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Angiotensin II Receptor Blocker (ARBs) API company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Valsartan
1.2.3 Irbesartan
1.2.4 Telmisartan
1.2.5 Losartan
1.2.6 Candesartan
1.2.7 Olmesartan
1.2.8 Others
1.3 Market by Application
1.3.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Essential Hypertension
1.3.3 Secondary Hypertension
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Perspective (2020-2031)
2.2 Global Angiotensin II Receptor Blocker (ARBs) API Growth Trends by Region
2.2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Region (2020-2025)
2.2.3 Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Region (2026-2031)
2.3 Angiotensin II Receptor Blocker (ARBs) API Market Dynamics
2.3.1 Angiotensin II Receptor Blocker (ARBs) API Industry Trends
2.3.2 Angiotensin II Receptor Blocker (ARBs) API Market Drivers
2.3.3 Angiotensin II Receptor Blocker (ARBs) API Market Challenges
2.3.4 Angiotensin II Receptor Blocker (ARBs) API Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Revenue
3.1.1 Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Revenue (2020-2025)
3.1.2 Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Players (2020-2025)
3.2 Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Angiotensin II Receptor Blocker (ARBs) API Revenue
3.4 Global Angiotensin II Receptor Blocker (ARBs) API Market Concentration Ratio
3.4.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angiotensin II Receptor Blocker (ARBs) API Revenue in 2024
3.5 Global Key Players of Angiotensin II Receptor Blocker (ARBs) API Head office and Area Served
3.6 Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Product and Application
3.7 Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Angiotensin II Receptor Blocker (ARBs) API Breakdown Data by Type
4.1 Global Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Type (2020-2025)
4.2 Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Type (2026-2031)
5 Angiotensin II Receptor Blocker (ARBs) API Breakdown Data by Application
5.1 Global Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Application (2020-2025)
5.2 Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
6.2 North America Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
6.4 North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
7.2 Europe Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
7.4 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
8.2 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2020-2025)
8.4 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
9.2 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
9.4 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
10.2 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
10.4 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Details
11.1.2 Teva Pharmaceutical Business Overview
11.1.3 Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.1.4 Teva Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.1.5 Teva Pharmaceutical Recent Development
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Company Details
11.2.2 Aurobindo Pharma Business Overview
11.2.3 Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.2.4 Aurobindo Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.2.5 Aurobindo Pharma Recent Development
11.3 Viatris
11.3.1 Viatris Company Details
11.3.2 Viatris Business Overview
11.3.3 Viatris Angiotensin II Receptor Blocker (ARBs) API Introduction
11.3.4 Viatris Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.3.5 Viatris Recent Development
11.4 Tianyu Pharma
11.4.1 Tianyu Pharma Company Details
11.4.2 Tianyu Pharma Business Overview
11.4.3 Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.4.4 Tianyu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.4.5 Tianyu Pharma Recent Development
11.5 Huahai Pharmaceutical
11.5.1 Huahai Pharmaceutical Company Details
11.5.2 Huahai Pharmaceutical Business Overview
11.5.3 Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.5.4 Huahai Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.5.5 Huahai Pharmaceutical Recent Development
11.6 Menovo
11.6.1 Menovo Company Details
11.6.2 Menovo Business Overview
11.6.3 Menovo Angiotensin II Receptor Blocker (ARBs) API Introduction
11.6.4 Menovo Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.6.5 Menovo Recent Development
11.7 Rundu Pharma
11.7.1 Rundu Pharma Company Details
11.7.2 Rundu Pharma Business Overview
11.7.3 Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.7.4 Rundu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.7.5 Rundu Pharma Recent Development
11.8 Kinglyuan Pharmaceutical
11.8.1 Kinglyuan Pharmaceutical Company Details
11.8.2 Kinglyuan Pharmaceutical Business Overview
11.8.3 Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.8.4 Kinglyuan Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.8.5 Kinglyuan Pharmaceutical Recent Development
11.9 Second Pharma
11.9.1 Second Pharma Company Details
11.9.2 Second Pharma Business Overview
11.9.3 Second Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.9.4 Second Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.9.5 Second Pharma Recent Development
11.10 Apeloa
11.10.1 Apeloa Company Details
11.10.2 Apeloa Business Overview
11.10.3 Apeloa Angiotensin II Receptor Blocker (ARBs) API Introduction
11.10.4 Apeloa Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.10.5 Apeloa Recent Development
11.11 Jiangxi Synergy Pharmaceutical
11.11.1 Jiangxi Synergy Pharmaceutical Company Details
11.11.2 Jiangxi Synergy Pharmaceutical Business Overview
11.11.3 Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.11.4 Jiangxi Synergy Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.11.5 Jiangxi Synergy Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Valsartan
1.2.3 Irbesartan
1.2.4 Telmisartan
1.2.5 Losartan
1.2.6 Candesartan
1.2.7 Olmesartan
1.2.8 Others
1.3 Market by Application
1.3.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Essential Hypertension
1.3.3 Secondary Hypertension
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Perspective (2020-2031)
2.2 Global Angiotensin II Receptor Blocker (ARBs) API Growth Trends by Region
2.2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Region (2020-2025)
2.2.3 Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Region (2026-2031)
2.3 Angiotensin II Receptor Blocker (ARBs) API Market Dynamics
2.3.1 Angiotensin II Receptor Blocker (ARBs) API Industry Trends
2.3.2 Angiotensin II Receptor Blocker (ARBs) API Market Drivers
2.3.3 Angiotensin II Receptor Blocker (ARBs) API Market Challenges
2.3.4 Angiotensin II Receptor Blocker (ARBs) API Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Revenue
3.1.1 Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Revenue (2020-2025)
3.1.2 Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Players (2020-2025)
3.2 Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Angiotensin II Receptor Blocker (ARBs) API Revenue
3.4 Global Angiotensin II Receptor Blocker (ARBs) API Market Concentration Ratio
3.4.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angiotensin II Receptor Blocker (ARBs) API Revenue in 2024
3.5 Global Key Players of Angiotensin II Receptor Blocker (ARBs) API Head office and Area Served
3.6 Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Product and Application
3.7 Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Angiotensin II Receptor Blocker (ARBs) API Breakdown Data by Type
4.1 Global Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Type (2020-2025)
4.2 Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Type (2026-2031)
5 Angiotensin II Receptor Blocker (ARBs) API Breakdown Data by Application
5.1 Global Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Application (2020-2025)
5.2 Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
6.2 North America Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
6.4 North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
7.2 Europe Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
7.4 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
8.2 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2020-2025)
8.4 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
9.2 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
9.4 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
10.2 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
10.4 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Details
11.1.2 Teva Pharmaceutical Business Overview
11.1.3 Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.1.4 Teva Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.1.5 Teva Pharmaceutical Recent Development
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Company Details
11.2.2 Aurobindo Pharma Business Overview
11.2.3 Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.2.4 Aurobindo Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.2.5 Aurobindo Pharma Recent Development
11.3 Viatris
11.3.1 Viatris Company Details
11.3.2 Viatris Business Overview
11.3.3 Viatris Angiotensin II Receptor Blocker (ARBs) API Introduction
11.3.4 Viatris Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.3.5 Viatris Recent Development
11.4 Tianyu Pharma
11.4.1 Tianyu Pharma Company Details
11.4.2 Tianyu Pharma Business Overview
11.4.3 Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.4.4 Tianyu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.4.5 Tianyu Pharma Recent Development
11.5 Huahai Pharmaceutical
11.5.1 Huahai Pharmaceutical Company Details
11.5.2 Huahai Pharmaceutical Business Overview
11.5.3 Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.5.4 Huahai Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.5.5 Huahai Pharmaceutical Recent Development
11.6 Menovo
11.6.1 Menovo Company Details
11.6.2 Menovo Business Overview
11.6.3 Menovo Angiotensin II Receptor Blocker (ARBs) API Introduction
11.6.4 Menovo Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.6.5 Menovo Recent Development
11.7 Rundu Pharma
11.7.1 Rundu Pharma Company Details
11.7.2 Rundu Pharma Business Overview
11.7.3 Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.7.4 Rundu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.7.5 Rundu Pharma Recent Development
11.8 Kinglyuan Pharmaceutical
11.8.1 Kinglyuan Pharmaceutical Company Details
11.8.2 Kinglyuan Pharmaceutical Business Overview
11.8.3 Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.8.4 Kinglyuan Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.8.5 Kinglyuan Pharmaceutical Recent Development
11.9 Second Pharma
11.9.1 Second Pharma Company Details
11.9.2 Second Pharma Business Overview
11.9.3 Second Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.9.4 Second Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.9.5 Second Pharma Recent Development
11.10 Apeloa
11.10.1 Apeloa Company Details
11.10.2 Apeloa Business Overview
11.10.3 Apeloa Angiotensin II Receptor Blocker (ARBs) API Introduction
11.10.4 Apeloa Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.10.5 Apeloa Recent Development
11.11 Jiangxi Synergy Pharmaceutical
11.11.1 Jiangxi Synergy Pharmaceutical Company Details
11.11.2 Jiangxi Synergy Pharmaceutical Business Overview
11.11.3 Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.11.4 Jiangxi Synergy Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.11.5 Jiangxi Synergy Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Valsartan
Table 3. Key Players of Irbesartan
Table 4. Key Players of Telmisartan
Table 5. Key Players of Losartan
Table 6. Key Players of Candesartan
Table 7. Key Players of Olmesartan
Table 8. Key Players of Others
Table 9. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2020-2025)
Table 13. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2026-2031)
Table 15. Angiotensin II Receptor Blocker (ARBs) API Market Trends
Table 16. Angiotensin II Receptor Blocker (ARBs) API Market Drivers
Table 17. Angiotensin II Receptor Blocker (ARBs) API Market Challenges
Table 18. Angiotensin II Receptor Blocker (ARBs) API Market Restraints
Table 19. Global Angiotensin II Receptor Blocker (ARBs) API Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Players (2020-2025)
Table 21. Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin II Receptor Blocker (ARBs) API as of 2024)
Table 22. Ranking of Global Top Angiotensin II Receptor Blocker (ARBs) API Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Angiotensin II Receptor Blocker (ARBs) API Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Headquarters and Area Served
Table 25. Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Product and Application
Table 26. Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Type (2020-2025)
Table 30. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Type (2026-2031)
Table 32. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Application (2020-2025)
Table 34. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Application (2026-2031)
Table 36. North America Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
Table 51. Teva Pharmaceutical Company Details
Table 52. Teva Pharmaceutical Business Overview
Table 53. Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
Table 54. Teva Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 55. Teva Pharmaceutical Recent Development
Table 56. Aurobindo Pharma Company Details
Table 57. Aurobindo Pharma Business Overview
Table 58. Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Product
Table 59. Aurobindo Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 60. Aurobindo Pharma Recent Development
Table 61. Viatris Company Details
Table 62. Viatris Business Overview
Table 63. Viatris Angiotensin II Receptor Blocker (ARBs) API Product
Table 64. Viatris Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 65. Viatris Recent Development
Table 66. Tianyu Pharma Company Details
Table 67. Tianyu Pharma Business Overview
Table 68. Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Product
Table 69. Tianyu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 70. Tianyu Pharma Recent Development
Table 71. Huahai Pharmaceutical Company Details
Table 72. Huahai Pharmaceutical Business Overview
Table 73. Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
Table 74. Huahai Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 75. Huahai Pharmaceutical Recent Development
Table 76. Menovo Company Details
Table 77. Menovo Business Overview
Table 78. Menovo Angiotensin II Receptor Blocker (ARBs) API Product
Table 79. Menovo Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 80. Menovo Recent Development
Table 81. Rundu Pharma Company Details
Table 82. Rundu Pharma Business Overview
Table 83. Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Product
Table 84. Rundu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 85. Rundu Pharma Recent Development
Table 86. Kinglyuan Pharmaceutical Company Details
Table 87. Kinglyuan Pharmaceutical Business Overview
Table 88. Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
Table 89. Kinglyuan Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 90. Kinglyuan Pharmaceutical Recent Development
Table 91. Second Pharma Company Details
Table 92. Second Pharma Business Overview
Table 93. Second Pharma Angiotensin II Receptor Blocker (ARBs) API Product
Table 94. Second Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 95. Second Pharma Recent Development
Table 96. Apeloa Company Details
Table 97. Apeloa Business Overview
Table 98. Apeloa Angiotensin II Receptor Blocker (ARBs) API Product
Table 99. Apeloa Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 100. Apeloa Recent Development
Table 101. Jiangxi Synergy Pharmaceutical Company Details
Table 102. Jiangxi Synergy Pharmaceutical Business Overview
Table 103. Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
Table 104. Jiangxi Synergy Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 105. Jiangxi Synergy Pharmaceutical Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Angiotensin II Receptor Blocker (ARBs) API Picture
Figure 2. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Type: 2024 VS 2031
Figure 4. Valsartan Features
Figure 5. Irbesartan Features
Figure 6. Telmisartan Features
Figure 7. Losartan Features
Figure 8. Candesartan Features
Figure 9. Olmesartan Features
Figure 10. Others Features
Figure 11. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Application: 2024 VS 2031
Figure 13. Essential Hypertension Case Studies
Figure 14. Secondary Hypertension Case Studies
Figure 15. Angiotensin II Receptor Blocker (ARBs) API Report Years Considered
Figure 16. Global Angiotensin II Receptor Blocker (ARBs) API Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Angiotensin II Receptor Blocker (ARBs) API Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region: 2024 VS 2031
Figure 19. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Players in 2024
Figure 20. Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin II Receptor Blocker (ARBs) API as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Angiotensin II Receptor Blocker (ARBs) API Revenue in 2024
Figure 22. North America Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
Figure 24. United States Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
Figure 28. Germany Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2020-2031)
Figure 36. China Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
Figure 44. Mexico Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
Figure 48. Turkey Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Teva Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 52. Aurobindo Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 53. Viatris Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 54. Tianyu Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 55. Huahai Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 56. Menovo Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 57. Rundu Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 58. Kinglyuan Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 59. Second Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 60. Apeloa Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 61. Jiangxi Synergy Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Valsartan
Table 3. Key Players of Irbesartan
Table 4. Key Players of Telmisartan
Table 5. Key Players of Losartan
Table 6. Key Players of Candesartan
Table 7. Key Players of Olmesartan
Table 8. Key Players of Others
Table 9. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2020-2025)
Table 13. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2026-2031)
Table 15. Angiotensin II Receptor Blocker (ARBs) API Market Trends
Table 16. Angiotensin II Receptor Blocker (ARBs) API Market Drivers
Table 17. Angiotensin II Receptor Blocker (ARBs) API Market Challenges
Table 18. Angiotensin II Receptor Blocker (ARBs) API Market Restraints
Table 19. Global Angiotensin II Receptor Blocker (ARBs) API Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Players (2020-2025)
Table 21. Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin II Receptor Blocker (ARBs) API as of 2024)
Table 22. Ranking of Global Top Angiotensin II Receptor Blocker (ARBs) API Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Angiotensin II Receptor Blocker (ARBs) API Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Headquarters and Area Served
Table 25. Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Product and Application
Table 26. Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Type (2020-2025)
Table 30. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Type (2026-2031)
Table 32. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Application (2020-2025)
Table 34. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Application (2026-2031)
Table 36. North America Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
Table 51. Teva Pharmaceutical Company Details
Table 52. Teva Pharmaceutical Business Overview
Table 53. Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
Table 54. Teva Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 55. Teva Pharmaceutical Recent Development
Table 56. Aurobindo Pharma Company Details
Table 57. Aurobindo Pharma Business Overview
Table 58. Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Product
Table 59. Aurobindo Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 60. Aurobindo Pharma Recent Development
Table 61. Viatris Company Details
Table 62. Viatris Business Overview
Table 63. Viatris Angiotensin II Receptor Blocker (ARBs) API Product
Table 64. Viatris Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 65. Viatris Recent Development
Table 66. Tianyu Pharma Company Details
Table 67. Tianyu Pharma Business Overview
Table 68. Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Product
Table 69. Tianyu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 70. Tianyu Pharma Recent Development
Table 71. Huahai Pharmaceutical Company Details
Table 72. Huahai Pharmaceutical Business Overview
Table 73. Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
Table 74. Huahai Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 75. Huahai Pharmaceutical Recent Development
Table 76. Menovo Company Details
Table 77. Menovo Business Overview
Table 78. Menovo Angiotensin II Receptor Blocker (ARBs) API Product
Table 79. Menovo Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 80. Menovo Recent Development
Table 81. Rundu Pharma Company Details
Table 82. Rundu Pharma Business Overview
Table 83. Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Product
Table 84. Rundu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 85. Rundu Pharma Recent Development
Table 86. Kinglyuan Pharmaceutical Company Details
Table 87. Kinglyuan Pharmaceutical Business Overview
Table 88. Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
Table 89. Kinglyuan Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 90. Kinglyuan Pharmaceutical Recent Development
Table 91. Second Pharma Company Details
Table 92. Second Pharma Business Overview
Table 93. Second Pharma Angiotensin II Receptor Blocker (ARBs) API Product
Table 94. Second Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 95. Second Pharma Recent Development
Table 96. Apeloa Company Details
Table 97. Apeloa Business Overview
Table 98. Apeloa Angiotensin II Receptor Blocker (ARBs) API Product
Table 99. Apeloa Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 100. Apeloa Recent Development
Table 101. Jiangxi Synergy Pharmaceutical Company Details
Table 102. Jiangxi Synergy Pharmaceutical Business Overview
Table 103. Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
Table 104. Jiangxi Synergy Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
Table 105. Jiangxi Synergy Pharmaceutical Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Angiotensin II Receptor Blocker (ARBs) API Picture
Figure 2. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Type: 2024 VS 2031
Figure 4. Valsartan Features
Figure 5. Irbesartan Features
Figure 6. Telmisartan Features
Figure 7. Losartan Features
Figure 8. Candesartan Features
Figure 9. Olmesartan Features
Figure 10. Others Features
Figure 11. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Application: 2024 VS 2031
Figure 13. Essential Hypertension Case Studies
Figure 14. Secondary Hypertension Case Studies
Figure 15. Angiotensin II Receptor Blocker (ARBs) API Report Years Considered
Figure 16. Global Angiotensin II Receptor Blocker (ARBs) API Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Angiotensin II Receptor Blocker (ARBs) API Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region: 2024 VS 2031
Figure 19. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Players in 2024
Figure 20. Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin II Receptor Blocker (ARBs) API as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Angiotensin II Receptor Blocker (ARBs) API Revenue in 2024
Figure 22. North America Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
Figure 24. United States Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
Figure 28. Germany Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2020-2031)
Figure 36. China Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
Figure 44. Mexico Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
Figure 48. Turkey Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Teva Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 52. Aurobindo Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 53. Viatris Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 54. Tianyu Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 55. Huahai Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 56. Menovo Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 57. Rundu Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 58. Kinglyuan Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 59. Second Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 60. Apeloa Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 61. Jiangxi Synergy Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232